QuantRate, a quantitative trading technology company specializing in AI-driven financial systems, today announced the launch ...

The harder question now is supervisory: how can regulators see, interpret and supervise digital asset activity across users, ...

Solana Unchained enters its final hours of Phase 3 as the project prepares for a transition in its token allocation structure. The ecosystem, which focuses on integrating machine learning tools with ...

As Toronto emerges as one of North America’s most active applied AI hubs, an Indian-origin engineering leader is among the practitioners building the quieter infrastructure — peer-reviewed research, ...

Over the past several years, we have seen accelerating technological change. Machine learning is accelerating drug discovery, ...

AI drug discovery cleared its first Phase IIa clinical test in 2025, as BIO 2026 confirmed the shift from speculation to ...

The Industrial Internet of Things has made machines visible. It is now shifting the focus from collecting data to acting on ...

Moderna expands beyond vaccines while Recursion bets on AI-driven drug discovery, each with distinct risks, partnerships, and financial profiles.

Teams are using AI to analyze data, speed up engineering work, and give drivers an edge. Now the FIA is writing rules to keep ...

G deployment continues its ascendancy worldwide, while attention is increasingly being given to the technologies that will ...

Rubin Observatory LSST launched June 30, 2026, unleashing a nightly 7-million-alert sky survey powered by SLAC’s 60-second ...

AbbVie’s $10.9B Apogee deal strengthens immunology beyond Humira, adds Zumilokibart optionality, and may be undervalued. See ...